Genvor GNVR

Genvor acquires IP from founder

Item 1.01 Enters material agreement

Form
8-K
Filed
Importance
Major
  1. Entered into IP assignment agreement with Dr. Jesse Jaynes
  2. Acquired 9,000 antimicrobial peptides
  3. Includes design and validation data

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when Genvor files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 100 and related industry codes: the same peer list as the financial tables.